Avantor, Inc.
Financials
Valuation Metrics
Avantor, Inc.'s Market Cap is $10.96B. At end of 2025 it was $7.77B. Ranked #833 of 3,115 in US market (top 27%), #576 of 1,643 on NYSE (top 35%), #58 of 203 in Health Care Equipment & Services (top 29%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $10.96B | US#833/3,115 Sec#58/203 |
| Revenue | $6.64B | US#744/3,115 Sec#40/203 |
| Net Income | $337M | US—/3,115 Sec—/203 |
| Total Assets | $11.63B | US#910/3,115 Sec#43/203 |
| Net Assets | $5.84B | US#639/3,115 Sec#38/203 |
| Employees | 13,500 | US#727/3,115 Sec#56/203 |
| Value | ||
| P/E | 32.50x | US—/3,115 Sec—/203 |
| P/B | 1.88x | US#1,285/3,115 Sec#54/203 |
| P/S | 1.65x | US#1,167/3,115 Sec#79/203 |
| EV/EBITDA | 15.59x | US#2,436/3,115 Sec#136/203 |
| FCF Yield | 4.01% | US#1,611/3,115 Sec#82/203 |
| Profitability | ||
| ROE | 5.78% | US#2,364/3,115 Sec#136/203 |
| ROA | 2.90% | US#2,512/3,115 Sec#139/203 |
| Op. Margin | 7.58% | US#2,438/3,115 Sec#145/203 |
| Revenue Growth | 0.92% | US#2,297/3,115 Sec#172/203 |
| Financial Health | ||
| Debt Ratio | 99.28% | US#1,143/3,115 Sec#107/203 |
| Total Debt | $3.68B | US#834/3,115 Sec#39/203 |
| FCF | $439M | US#939/3,115 Sec#52/203 |
| Cash | $464M | US#1,392/3,115 Sec#76/203 |
| Current Ratio | 1.89x | US#1,392/3,115 Sec#122/203 |
| Net Debt/EBITDA | 3.54x | US#2,484/3,115 Sec#143/203 |
| Performance | ||
| 1Y Return | 45.25% | US#1,383/3,115 Sec#109/203 |
| 1M Return | 6.64% | US#638/3,115 Sec#69/203 |
| From 52W High | -8.02% | US#347/3,115 Sec#42/203 |
| 1Y MDD | -41.19% | US#1,986/3,115 Sec#125/203 |
| Trading | ||
| Volume | 8,152,014 shares | US#42/3,115 Sec#3/203 |
| Trading Value | $132M | US#224/3,115 Sec#16/203 |
| Per Share | ||
| EPS | $0.49 | US—/3,115 Sec—/203 |
| BPS | $8.55 | US#1,967/3,115 Sec#113/203 |
Company Info
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.